2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-{3,5-dihydroxy-4-[(1E)-3-methylbut-1-en-1-yl]phenyl}-2-hydroxy-1-(4-hydroxyphenyl)ethyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

Metabolite details

Identifier

SDVJPEMTFZUUKK-FPYGCLRLSA-N

InChI Key

SDVJPEMTFZUUKK-FPYGCLRLSA-N

IUPAC name

2-amino-5-[[1-(carboxymethylamino)-3-[2-[3,5-dihydroxy-4-[(E)-3-methylbut-1-enyl]phenyl]-2-hydroxy-1-(4-hydroxyphenyl)ethyl]sulanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

Preferred name

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-{3,5-dihydroxy-4-[(1E)-3-methylbut-1-en-1-yl]phenyl}-2-hydroxy-1-(4-hydroxyphenyl)ethyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

INN name

—

Synonym

—

ChEBI

CHEBI:184164

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis

Observed in differential profiles

• Control_vs_nsPEF_7_day
• Control_vs_Exercise
• G1_PBS_vs_G2_DSS
• Control_vs_ZYP_High_Dose